gene therapy

Non-Endocytic Transmembrane Delivery for Precision Medicine

by

Non-endocytic transmembrane delivery strategies are emerging to bypass canonical cellular uptake routes, directly addressing the low endosomal escape efficiency that has long hindered the clinical translation of therapeutic biomacromolecules like mRNA and gene-editing tools. According to a review published in Biomedical Analysis, these advanced platforms offer a direct path to the cytosol, potentially reshaping the … Read more

Tailored Gene Therapy Significantly Reduces Childhood Epilepsy Seizures

by

Researchers at the University of California San Diego and the Rady Children’s Institute for Genomic Medicine have successfully treated two children with SCN2A-related developmental epileptic encephalopathy (DEE) using personalized, allele-selective antisense oligonucleotides (ASOs). According to a study published July 21, 2026, in Nature Medicine, the therapy reduced seizure frequency by up to 90%, improved developmental … Read more

New Lead Named for Houston Methodist Cell and Gene Therapy Research

by

Houston Methodist has appointed physician-scientist Malcolm Brenner to lead its newly established Center for Cell and Gene Therapy, aiming to accelerate the transition of laboratory discoveries into clinical treatments. According to Houston Methodist, the center will integrate academic research with clinical care to develop therapies for both congenital and acquired diseases by uniting multidisciplinary expertise … Read more

First Precise Human Embryo Gene Editing Sparks Ethical Debate

by

The Dawn of Precision Genetics: Is Designer DNA Within Reach? A new frontier in biotechnology has opened, and it’s sparking one of the most significant ethical debates of our generation. Researchers at Columbia University have successfully utilized base editing—a highly precise genome-editing technique—to modify human embryos. Unlike the “cut-and-paste” methods of early CRISPR, which often … Read more

Cell and Gene Therapy: Bridging Insight and Urgency

by

The Great Balancing Act: Navigating the Industrialization of Cell and Gene Therapy The cell and gene therapy (CGT) sector is currently undergoing a fundamental metamorphosis. We are moving away from the “discovery at all costs” era and into a high-stakes phase where biological complexity must coexist with industrial-scale predictability. For researchers and biotech leaders, the … Read more

New gene therapy improves hearing in patients with rare genetic deafness

by

The Novel Frontier of Genetic Hearing Restoration The landscape of treating inherited deafness is shifting from managing hearing loss to potentially reversing it. Recent breakthroughs in gene therapy are demonstrating that it is possible to restore hearing in individuals born deaf, offering a glimpse into a future where genetic mutations no longer dictate a lifetime … Read more

Multicentre gene therapy for OTOF-related deafness followed up to 2.5 years

by

Beyond the Implant: The Rise of Biological Hearing Restoration For decades, cochlear implantation has been the gold standard for treating profound congenital deafness. However, a paradigm shift is occurring. We are moving from mechanical stimulation of the auditory nerve to the biological restoration of the ear’s own cellular machinery. View this post on Instagram about … Read more

Base editing corrects genetic mutation responsible for severe form of inherited epilepsy

by

Gene Editing Offers Novel Hope for Epilepsy Treatment: A Turning Point in Neuroscience Scientists at the University of Virginia (UVA) have achieved a significant breakthrough in epilepsy research, successfully reversing severe seizures in lab mice using a next-generation gene editing technique called base editing. This promising development, published in the Journal of Clinical Investigation, signals … Read more

FDA Approves Gene Therapy for Rare LAD-1 Immune Deficiency | Kresladi

by

FDA Greenlights First Gene Therapy for LAD-I: A Latest Era for Rare Disease Treatment In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved Kresladi (marnetegragene autotemcel), a gene therapy developed by Rocket Pharmaceuticals, for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I). This approval marks the first FDA-approved gene … Read more

Rare Pediatric Gene Therapy: Faster Approvals Blueprint

by

The Future of Hope: Accelerating Gene Therapy for Children Rare pediatric diseases, once considered medical mysteries, are increasingly becoming targets for groundbreaking cell and gene therapies. Recent advancements are dramatically shortening the time it takes to develop and deliver these potentially life-saving treatments, offering a beacon of hope for families facing previously untreatable conditions. From … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]